Danisco and DuPont already have a history of working together, as they are partnering over the development of second generation biofuels. DuPont Chair and CEO Ellen Kullman said: “Danisco has attractive, market-driven science businesses that offer clear synergies with DuPont Nutrition & Health and Applied BioSciences. “This transaction is a perfect strategic fit with our growth opportunities and will help us solve global challenges presented by dramatic population growth in the decades to come, specifically related to food and energy.” The acquisition, which is expected to close in Q2 2011, is expected to take a toll on earnings per share; outlook for 2011 would be reduced by between $0.30 and $0.45 per share, from the previously stated $3.30 to $3.60. DuPont has said it expects Danisco to contribute to cash and earnings in 2012, the first full year of combined operations.
